The Traderszone Network

Published in TZ Latest News 8 November, 2015 by The TZ Newswire Staff

Agios Announces Data from Dose-Escalation Phase 1 Study of AG-120 in Patients with IDH1 Mutant Positive Advanced Solid Tumors